Drug Shortage Report for LOVASTATIN
Report ID | 30941 |
Drug Identification Number | 02220172 |
Brand name | APO-LOVASTATIN - TAB 20MG |
Common or Proper name | LOVASTATIN |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LOVASTATIN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 BTL |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-11-27 |
Estimated end date | 2018-09-10 |
Actual end date | 2018-09-10 |
Shortage status | Resolved |
Updated date | 2018-09-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2018-09-11 | English | Compare |
v11 | 2018-09-10 | French | Compare |
v10 | 2018-09-10 | English | Compare |
v9 | 2018-09-10 | English | Compare |
v8 | 2018-08-22 | French | Compare |
v7 | 2018-08-22 | English | Compare |
v6 | 2018-05-15 | French | Compare |
v5 | 2018-05-15 | English | Compare |
v4 | 2018-04-10 | French | Compare |
v3 | 2018-04-10 | English | Compare |
v2 | 2017-11-28 | French | Compare |
v1 | 2017-11-28 | English | Compare |
Showing 1 to 12 of 12